16.30

4.20% -0.715

After Hours: 16.31 0.005 +0.03%

Jade Biosciences Inc (JBIO)

Overview News Price History Discussions Forecast

Jade Biosciences Inc stock is traded at $16.30, with a volume of 304.18K. It is down -4.20% in the last 24 hours and down -0.28% over the past month. Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

Previous Close:

$17.02

Open:

$16.87

24h Volume:

304.18K

Relative Volume:

1.04

Market Cap:

$804.07M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+10.92%

1M Performance:

-0.28%

6M Performance:

+87.20%

1Y Performance:

+0.00%

1-Day Range:

$15.80

$16.95

1-Week Range:

$14.30

$17.11

52-Week Range:

$6.565

$17.71

Jade Biosciences Inc Stock (JBIO) Company Profile

Name

Jade Biosciences Inc

Sector

Healthcare (1112)

Industry

Biotechnology (625)

Phone

(781) 312-3013

Address

221 CRESCENT ST., WALTHAM

Employee

Twitter

Next Earnings Date

2025-05-19

Latest SEC Filings

JBIO's Discussions on Twitter

Compare JBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JBIO Jade Biosciences Inc	16.30	839.33M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	468.41	118.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	753.55	79.40B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	814.74	51.18B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	357.98	48.88B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	339.32	37.49B	4.98B	69.59M	525.67M	0.5197

Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-07-26	Initiated	H.C. Wainwright	Buy
Oct-09-25	Initiated	BTIG Research	Buy
Jul-14-25	Initiated	Jefferies	Buy
Jun-16-25	Upgrade	Guggenheim	Neutral → Buy
May-07-25	Initiated	Wedbush	Outperform
May-05-25	Initiated	Stifel	Buy
May-02-25	Initiated	TD Cowen	Buy
Jun-18-24	Downgrade	Evercore ISI	Outperform → In-line
Jun-18-24	Downgrade	TD Cowen	Buy → Hold
Jun-18-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-17-24	Downgrade	BTIG Research	Buy → Neutral
Jun-17-24	Downgrade	Guggenheim	Buy → Neutral
Jun-17-24	Downgrade	Wedbush	Outperform → Neutral
Mar-25-24	Resumed	Jefferies	Buy
Dec-08-23	Initiated	Wells Fargo	Equal Weight
Mar-01-23	Initiated	Guggenheim	Buy
Dec-06-22	Upgrade	BTIG Research	Neutral → Buy
Sep-19-22	Resumed	Wedbush	Outperform
Aug-16-22	Downgrade	BTIG Research	Buy → Neutral
Feb-11-22	Initiated	BTIG Research	Buy
Jul-26-21	Initiated	Cowen	Outperform
Jul-26-21	Initiated	Evercore ISI	Outperform
Jul-26-21	Initiated	Jefferies	Buy
Jul-26-21	Initiated	Wedbush	Outperform

View All

Jade Biosciences Inc Stock (JBIO) Latest News

02:18 AM

Jade Biosciences (NASDAQ:JBIO) Stock Price Down 5.3%Here's What Happened - MarketBeat

02:18 AM

Jan 21, 2026

What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN

Jan 21, 2026

Jan 19, 2026

H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue - Finviz

Jan 19, 2026

Jan 18, 2026

Short Interest in Jade Biosciences, Inc. (NASDAQ:JBIO) Increases By 47.9% - MarketBeat

Jan 18, 2026

Jan 17, 2026

Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 17, 2026

Jan 16, 2026

Breakout Watch: What is AvePoint Incs TAM Total Addressable MarketMarket Trend Report & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Jan 16, 2026

Jan 15, 2026

JBIO: Advancing novel autoimmune therapies with strong data, market potential, and rapid clinical timelines - TradingView — Track All Markets

Jan 15, 2026

Jan 14, 2026

Valuation Update: What is the PEG ratio of Jade Biosciences IncJuly 2025 PostEarnings & AI Enhanced Trading Alerts - baoquankhu1.vn

Jan 14, 2026

Jade Biosciences (NASDAQ:JBIO) Trading Down 4.8%Should You Sell? - MarketBeat

Jan 14, 2026

Jan 10, 2026

Published on: 2026-01-10 20:20:04 - ulpravda.ru

Jan 10, 2026

How risky is Jade Biosciences Inc. stock nowPortfolio Profit Report & Fast Entry and Exit Trade Plans - Улправда

Jan 10, 2026

Will Jade Biosciences Inc. stock rally after Fed decisionsJuly 2025 Final Week & Real-Time Chart Pattern Alerts - Улправда

Jan 10, 2026

Jan 09, 2026

How Jade Biosciences Inc. stock reacts to global recession fearsFit and Size Notes & quick comparison of popular models - Улправда

Jan 09, 2026

Equities Analysts Offer Predictions for JBIO FY2025 Earnings - MarketBeat

Jan 09, 2026

How Jade Biosciences Inc. stock reacts to job market dataJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - Улправда

Jan 09, 2026

Jade Biosciences (NASDAQ:JBIO) Coverage Initiated at HC Wainwright - Defense World

Jan 09, 2026

Jan 08, 2026

Why Jade Biosciences Inc. stock is popular among millennialsQuarterly Portfolio Review & Daily Growth Stock Tips - Улправда

Jan 08, 2026

Will Jade Biosciences Inc. stock benefit from sector rotationPortfolio Performance Summary & Stepwise Trade Signal Implementation - Улправда

Jan 08, 2026

Why Jade Biosciences Inc. stock remains a top recommendationMarket Activity Report & Expert Approved Momentum Ideas - Улправда

Jan 08, 2026

Jade Biosciences (NASDAQ:JBIO) Upgraded to Strong-Buy at HC Wainwright - MarketBeat

Jan 08, 2026

Jan 07, 2026

Jade Biosciences (NASDAQ:JBIO) Shares Gap UpShould You Buy? - MarketBeat

Jan 07, 2026

H.C. Wainwright initiates coverage on Jade Biosciences stock with Buy rating - Investing.com India

Jan 07, 2026

This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga

Jan 07, 2026

HC Wainwright & Co. Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq

Jan 07, 2026

Jan 06, 2026

Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN

Jan 06, 2026

Institutional Investors of Jade Biosciences, Inc. (NASDAQ:JBIO) Must Be Disappointed After Last Week's 16% Drop - 富途牛牛

Jan 06, 2026

Does Jade Biosciences, Inc. (JBIO) have the potential to rally 65% as Wall Street analysts expect? - MSN

Jan 06, 2026

The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares - simplywall.st

Jan 06, 2026

Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance

Jan 06, 2026

Jade Biosciences outlines 2026 clinical pipeline and milestones By Investing.com - Investing.com Nigeria

Jan 06, 2026

Jan 05, 2026

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5%Here's What Happened - MarketBeat

Dec 24, 2025

Dec 23, 2025

Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating - MarketScreener

Dec 23, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 23, 2025

Volume Report: Why Jade Biosciences Inc stock is popular among millennials2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn

Dec 23, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Dec 23, 2025

Dec 22, 2025

Jade Biosciences files for offering of 3.2 million shares of common stock by selling stockholderSEC filing - marketscreener.com

Dec 22, 2025

Jade Biosciences (NASDAQ:JBIO) Trading Down 4.5%Here's What Happened - MarketBeat

Dec 22, 2025

What analysts say about Jade Biosciences Inc stockStock Liquidity Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in

Dec 22, 2025